Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut
08/05/2026 16:54
May 8 (Reuters) - Odyssey Therapeutics ODTX.O shares rose 11.1% in its Nasdaq debut on Friday, giving the biopharmaceutical firm a valuation of $899.9 million. (Reporting by Prakhar Srivastava in Bengaluru; Editing by Vijay Kishore) ((Prakhar.srivastava2@thomsonreuters.com;))